Traumatic Brain Injury and Alzheimer's Disease/Related Dementias Caregiver Support Intervention

Launched by UNIVERSITY OF MINNESOTA · Jul 15, 2022

Keywords

ClinConnect Summary

The Traumatic Brain Injury and Alzheimer's Disease/Related Dementias Caregiver Support Intervention (TACSI) clinical trial is designed to help family caregivers who are taking care of loved ones with both traumatic brain injury (TBI) and dementia. The goal of this study is to identify the challenges that caregivers face and provide them with tools and strategies to manage stress, improve communication, and feel more confident in their caregiving roles.

To participate in this trial, caregivers must be at least 21 years old, speak English, and be the primary support person for someone diagnosed with both TBI and dementia. Participants will receive support tailored to their needs and can expect to engage in discussions about their caregiving experiences. It’s important to note that caregivers who are currently dealing with significant mental health issues and not receiving treatment may not be eligible to join. This trial is currently recruiting participants across the United States.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • the care recipient has a physician diagnosis of TBI and AD/ADRD (i.e., those with a diagnosis of both TBI and progressive cognitive decline)
• • the caregiver self-identifies as someone who provides the most help/is most responsible for the person with TBI-AD/ADRD because of their cognitive impairments (or shares the role equally with another caregiver)
• • the caregiver indicates a willingness to participate in the TACSI evaluation
• • the caregiver is English speaking
• • the caregiver is 21 years of age or older
• • the caregiver is not currently participating in any other type of service that provides one-to-one psychosocial consultation or caregiver coaching (peer mentorship/support group participation/general counseling not specific to caregiving is not a deterrent to enrollment) at the discretion of the UMN research team
• • the caregiver resides in the US.
• Exclusion Criteria:
• • caregivers who have a new or worsening mental health condition and are not receiving ongoing treatment. When applicable, if caregivers have not remained on a stable psychotropic medications dosage, such as antidepressants, anxiolytics or anti-psychotics, for the prior three months they will be excluded.